III Thomas F. Zenty

III Thomas F. Zenty is a declared insider of Endologix Inc /DE/, with filings sourced from SEC (Form 4). We count 11 filings; the first trade dates from 23 May 2013 and the latest from 5 August 2019.

Purchases make up the whole of the open-market record (4 purchases, €78k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants. 2019 to date brings 1 purchase and no sales.

The median purchase comes to €19k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 6 August 2019 with a share grant in Endologix Inc /DE/. The last purchase on record was published on 3 April 2019, which is 2,777 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.